X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA JUBILANT LIFE SCIENCES TORRENT PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 29.2 28.0 104.2% View Chart
P/BV x 5.5 5.7 96.5% View Chart
Dividend Yield % 1.0 0.3 310.3%  

Financials

 TORRENT PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-17
JUBILANT LIFE SCIENCES
Mar-14
TORRENT PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,768187 946.4%   
Low Rs1,18665 1,821.2%   
Sales per share (Unadj.) Rs346.1364.3 95.0%  
Earnings per share (Unadj.) Rs55.26.8 805.9%  
Cash flow per share (Unadj.) Rs73.324.5 299.2%  
Dividends per share (Unadj.) Rs14.003.00 466.7%  
Dividend yield (eoy) %0.92.4 39.8%  
Book value per share (Unadj.) Rs257.1164.9 155.9%  
Shares outstanding (eoy) m169.22159.28 106.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.30.3 1,234.2%   
Avg P/E ratio x26.818.4 145.5%  
P/CF ratio (eoy) x20.15.1 391.8%  
Price / Book Value ratio x5.70.8 752.1%  
Dividend payout %25.443.8 57.9%   
Avg Mkt Cap Rs m249,88720,061 1,245.6%   
No. of employees `00011.86.2 190.5%   
Total wages/salary Rs m9,93411,052 89.9%   
Avg. sales/employee Rs Th4,971.59,383.0 53.0%   
Avg. wages/employee Rs Th843.21,786.9 47.2%   
Avg. net profit/employee Rs Th792.4176.3 449.5%   
INCOME DATA
Net Sales Rs m58,56958,034 100.9%  
Other income Rs m2,233191 1,171.6%   
Total revenues Rs m60,80258,224 104.4%   
Gross profit Rs m13,7735,786 238.0%  
Depreciation Rs m3,0692,812 109.2%   
Interest Rs m2,0563,237 63.5%   
Profit before tax Rs m10,881-72 -15,091.4%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m1,545696 221.9%   
Profit after tax Rs m9,3361,090 856.2%  
Gross profit margin %23.510.0 235.8%  
Effective tax rate %14.2-965.9 -1.5%   
Net profit margin %15.91.9 848.4%  
BALANCE SHEET DATA
Current assets Rs m53,84129,280 183.9%   
Current liabilities Rs m31,61238,912 81.2%   
Net working cap to sales %38.0-16.6 -228.7%  
Current ratio x1.70.8 226.3%  
Inventory Days Days9784 115.2%  
Debtors Days Days8451 165.3%  
Net fixed assets Rs m42,07955,712 75.5%   
Share capital Rs m846155 547.7%   
"Free" reserves Rs m42,65520,968 203.4%   
Net worth Rs m43,50126,265 165.6%   
Long term debt Rs m22,40817,169 130.5%   
Total assets Rs m101,25088,606 114.3%  
Interest coverage x6.31.0 643.7%   
Debt to equity ratio x0.50.7 78.8%  
Sales to assets ratio x0.60.7 88.3%   
Return on assets %11.34.9 230.4%  
Return on equity %21.54.2 516.9%  
Return on capital %19.611.6 169.7%  
Exports to sales %037.8 0.0%   
Imports to sales %016.5 0.0%   
Exports (fob) Rs mNA21,933 0.0%   
Imports (cif) Rs mNA9,567 0.0%   
Fx inflow Rs m20,06622,004 91.2%   
Fx outflow Rs m5,30411,749 45.1%   
Net fx Rs m14,76210,255 143.9%   
CASH FLOW
From Operations Rs m10,1278,026 126.2%  
From Investments Rs m-7,869-1,744 451.2%  
From Financial Activity Rs m-1,918-4,447 43.1%  
Net Cashflow Rs m2121,834 11.5%  

Share Holding

Indian Promoters % 71.5 45.6 156.8%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 7.0 8.7 80.7%  
FIIs % 12.6 21.2 59.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 21.1 41.7%  
Shareholders   26,511 23,815 111.3%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   AUROBINDO PHARMA  MERCK LTD  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare TORRENT PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Banking Sector Up 1.5%(11:30 am)

Stock markets in India have continued their momentum and are presently trading on a positive note. All sectoral indices are trading on a positive note with stocks in the banking sector.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jan 18, 2018 01:17 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS